BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8819551)

  • 1. Myasthenia gravis in childhood.
    Anlar B; Ozdirim E; Renda Y; Yalaz K; Aysun S; Topçu M; Topaloğlu H
    Acta Paediatr; 1996 Jul; 85(7):838-42. PubMed ID: 8819551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine receptor antibodies in juvenile myasthenia gravis.
    Andrews PI; Massey JM; Sanders DB
    Neurology; 1993 May; 43(5):977-82. PubMed ID: 8492956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.
    Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C
    Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Myasthenia Gravis.
    Peragallo JH
    Semin Pediatr Neurol; 2017 May; 24(2):116-121. PubMed ID: 28941526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Ocular Features of Pediatric Myasthenias.
    Mansukhani SA; Bothun ED; Diehl NN; Mohney BG
    Am J Ophthalmol; 2019 Apr; 200():242-249. PubMed ID: 30653958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile Myasthenia Gravis in North Texas: Clinical Features, Treatment Response, and Outcomes.
    Lu M; Reisch J; Iannaccone S; Batley K
    Pediatr Neurol; 2024 Jul; 156():10-14. PubMed ID: 38688232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and evolution of juvenile myasthenia gravis in a French cohort.
    Barraud C; Desguerre I; Barnerias C; Gitiaux C; Boulay C; Chabrol B
    Muscle Nerve; 2018 Apr; 57(4):603-609. PubMed ID: 28877546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms.
    Hong Y; Skeie GO; Zisimopoulou P; Karagiorgou K; Tzartos SJ; Gao X; Yue YX; Romi F; Zhang X; Li HF; Gilhus NE
    J Neurol; 2017 May; 264(5):955-962. PubMed ID: 28364296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile myasthenia gravis with prepubertal onset.
    Evoli A; Batocchi AP; Bartoccioni E; Lino MM; Minisci C; Tonali P
    Neuromuscul Disord; 1998 Dec; 8(8):561-7. PubMed ID: 10093062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile myasthenia gravis: a twenty-year experience.
    Castro D; Derisavifard S; Anderson M; Greene M; Iannaccone S
    J Clin Neuromuscul Dis; 2013 Mar; 14(3):95-102. PubMed ID: 23492460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
    Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
    J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
    Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
    BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological follow-up in juvenile myasthenia: clinical and acetylcholine receptor antibody status of patients followed for at least 2 years.
    Anlar B; Senbil N; Köse G; Değerliyurt A
    Neuromuscul Disord; 2005 May; 15(5):355-7. PubMed ID: 15833428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-onset myasthenia gravis.
    Roach ES; Buono G; McLean WT; Weaver RG
    J Pediatr; 1986 Feb; 108(2):193-7. PubMed ID: 3944702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Mullaney P; Vajsar J; Smith R; Buncic JR
    Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of children with acetylcholine receptor (AChR) antibody positive juvenile myasthenia gravis following thymectomy.
    Heng HS; Lim M; Absoud M; Austin C; Clarke D; Wraige E; Reid C; Robb SA; Jungbluth H
    Neuromuscul Disord; 2014 Jan; 24(1):25-30. PubMed ID: 24239058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
    Popperud TH; Boldingh MI; Brunborg C; Faiz KW; Heldal AT; Maniaol AH; Müller KI; Rasmussen M; Øymar K; Kerty E
    Eur J Paediatr Neurol; 2017 Mar; 21(2):312-317. PubMed ID: 27666466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prepubertal anti-Musk positive myasthenia gravis with long remission.
    Gungor-Tuncer O; Orhan EK; Yilmaz V; Parman Y; Oflazer P; Saruhan-Direskeneli G; Deymeer F
    Neuromuscul Disord; 2014 Jan; 24(1):36-9. PubMed ID: 24074501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile myasthenia gravis: recommendations for diagnostic approaches and treatment.
    Della Marina A; Trippe H; Lutz S; Schara U
    Neuropediatrics; 2014 Apr; 45(2):75-83. PubMed ID: 24470240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographics and ocular findings in children with myasthenia.
    Arruti N; Munot P; Bowman R
    Eye (Lond); 2023 Mar; 37(4):700-704. PubMed ID: 35338356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.